Pr Daniel Chevallier

Chirurgien urologue et Praticien Hospitalier Universitaire, formé à la Faculté de Nice Sophia-Antipolis. Son expérience médicale est particulièrement prononcée dans l’Andrologie médicale et chirurgicale, pour laquelle Pr Daniel Chevallier s’implique dans plusieurs programmes de recherche clinique au sein de son établissement et au sein de sociétés savantes internationales.

INFORMATIONS SUR LA CONSULTATION

• Secrétariat Médical pour prendre rendez-vous : 04.92.03.71.10
• Mardi matin (public) à l’Hôpital Pasteur 2 – CHU de Nice
• Mardi après-midi (privé) à l’Hôpital Pasteur 2 – CHU de Nice

CHIRURGIEN UROLOGUE 

• Professeur convention de l’Université de Médecine de Nice Sophia-Antipolis, France
• Praticien Hospitalier (1990) – CHU de Nice, France
• Chirurgien urologue (1992) – CHU de Nice, France
• Docteur en médecine (1988) – CHU de Nice, France

ACTIVITÉS, TITRES ACADÉMIQUES & HOSPITALIERS 

• Chef de Service d’Urologie, Andrologie et Transplantation Rénale du CHU de Nice
• Responsable de l’Unité Fonctionnelle de l’Hôpital Conventionnel d’Urologie du CHU de Nice
• DU d’étude de la sexualité (2013)
• DU de pédagogie médicale et simulation en sciences de la santé (2012)
• Co-Responsable pédagogique du Centre de simulations chirurgicales à la Faculté de Médecine de Nice Sophia-Antipolis (2009)
• DIU de chirurgie de la verge (2008)
• Membre département de pédagogie médicale de médecine de Nice (2002)
• Membre de l’Association Française d’Urologie (AFU) et du Comité d’Andrologie
• Membre de l’International Society for Sexual Medicine (ISSM)

RECHERCHE CLINIQUE

• Investigateur Principal – Etude ONDELA (2022)
• Investigateur associé – Etude REMEEX (2017)
• Investigateur associé – Etude HIFI (2015)
• Investigateur associé – Etude PRECOCE (2014) 

ACTIVITÉS D’ENSEIGNEMENTS 

• Enseignement de l’Urologie étudiants 1er et 2ème cycle à la Faculté de Médecine de Nice Sophia-Antipolis
• Membre pédagogique SIDES à la Faculté de Médecine de Nice Sophia-Antipolis

COMMUNICATIONS ORALES & POSTERS 

• Potential sexual consequences associated with benign prostatic hyperplasia and its treatments.Chevallier D. et al. – AFU 2004 (Paris)
• La Peyronie disease. Historical, epidemiological, physiopathological data. Diagnostic and therapeutic approaches.Chevallier D. et al. – AFU 1997 (Paris)
• Intraprostatic spiral for the treatment of benign prostatic hypertrophy. A new method of insertion with sonographic monitoring. Apropos of 35 patients.Chevallier D. et al. – AFU – 1990 (Paris)
• Gangrenous states of the perineum and genital region. Chevallier D. et al. – AFU – 1987 (Paris)

PUBLICATIONS & OUVRAGES SCIENTIFIQUES

• Peyronie’s Disease: update in 2020. Faix A, Chevallier D, Bettocchi C, Djinovic R, Ralph D.Rev Med Suisse. (2020)
• Penile prosthesis in the treatment of erectile dysfunction: updates in 2020. Chevallier D, Faix A, Bettocchi C, Djinovic R, Ralph D.Rev Med Suisse. (2020)
• Intracorporeal urinary diversion during robot-assisted radical cystectomy using indocyanine green. Jeglinschi S, Carlier M, Denimal L, Guillonneau B, Chevallier D, Tibi B, Durand M, Ahallal Y.Can J Urol. (2020)
• Safety of dual kidney transplantation compared to single kidney transplantation from expanded criteria donors: a single center cohort study of 39 recipients. Mendel L, Albano L, Bentellis I, Yandza T, Bernardi C, Quintens H, Tibi B, Jourdan J, Durand M, Amiel J, Chevallier D. Transpl Int. (2018)
• Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series. Prader R, De Broca B, Chevallier D, Amiel J, Durand M. J Endourol. (2017)
• Percutaneous nephrolithotomy for kidney stones in elderly patients: Meta-analysis of results and complications. Haider R, Regnier P, Roustan FR, Séverac F, Treacy PJ, Mendel L, Bodokh Y, Tibi B, Prader R, Traxer O, Chevallier D, Amiel J, Durand M. Prog Urol. (2017)
• Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, Amiel J, Kee DL, Hannoun-Lévi JM. Radiat Oncol. (2017)
• Developmental epigenetic programming of adult germ cell death disease: Polycomb protein EZH2-miR-101 pathway. Siddeek B, Lakhdari N, Inoubli L, Paul-Bellon R, Isnard V, Thibault E, Bongain A, Chevallier D, Repetto E, Trabucchi M, Michiels JF, Yzydorczyk C, Simeoni U, Urtizberea M, Mauduit C, Benahmed M. Epigenomics. (2016)
• Real-time in vivo periprostatic nerve tracking using multiphoton microscopy in a rat survival surgery model: a promising pre-clinical study for enhanced nerve-sparing surgery.Durand M, Jain M, Aggarwal A, Robinson BD, Srivastava A, Smith R, Sooriakumaran P, Loeffler J, Pumill C, Amiel J, Chevallier D, Mukherjee S, Tewari AK. BJU Int. (2015)
• Quelle est la meilleure prise en charge chirurgicale du prolapsus chez la femme âgée de 70 à 80ans ?Tibi B, Vincens E, Durand M, Salet-Lizet D, Gadonneix P, Kane A, Carpentier X, Marsaud A, Rouscoff Y, Chevallier D, Amiel J, Villet R.Prog Urol. (2015)
• La photovaporisation transurétrale de prostate par GreenLight 180W permet-elle de désonder précocement les patients opérés de leur adénome ? Haider R, Donzeau D, Marsaud A, Tibi B, Chevallier D, Amiel J, Durand M.Prog Urol. (2015)
• Elastography shows promise in testicular cancer detection].Marsaud A, Durand M, Raffaelli C, Carpentier X, Rouscoff Y, Tibi B, Floc’h A, De Villeneuve MH, Haider R, Ambrosetti D, Fontas E, Padovani B, Amiel J, Chevallier D.Prog Urol. (2015)
• High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis. Rouscoff Y, Falk AT, Durand M, Gal J, Chand ME, Gautier M, Marsaud A, Chevallier D, Amiel J, Hannoun-Levi JM. Radiat Oncol. (2014)
• Salvage HIFU after radiotherapy and salvage radiotherapy after HIFU in locally recurrent prostate cancer: Retrospective analysis of morbidity. Lee JW, Chevallier D, Gal J, Rouscoff Y, Natale R, Chand ME, Raffaelli C, Ambrosetti D, Durand M, Amiel J, Hannoun-Levi JM.Prog Urol. (2014)
• Évaluation du désondage précoce après photovaporisation transurétrale de prostate par GreenLight 180W : résultats préliminaires, faisabilité et perspectives d’optimisation. Durand M, Colomb F, Marsaud A, Rouscoff Y, Lee J, Mendel L, Carpentier X, Haider R, Chevallier D, Carles M.Prog Urol. (2014)
• Évaluation du profil plasmatique des microARNs, comme marqueur diagnostic du cancer localisé de la prostate avec confirmation des analyses par prélèvement tissulaire sur spécimens après prostatectomie radicale élargie.Tibi B, Durand M, Rouscoff Y, Lee J, Mauduit C, Ambrosetti D, Mahate Z, Wijeratne V, Severac F, Carpentier X, Marsaud A, Mentine N, Quintens H, Amiel J, Chevallier D, Benahmed M.Prog Urol. (2014)
• High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.Rouscoff Y, Falk AT, Durand M, Gal J, Chand ME, Gautier M, Marsaud A, Chevallier D, Amiel J, Hannoun-Levi JM.Radiat Oncol. (2014)
• Ipsilateral dual kidney transplantation: a monocentric experience about 15 cases and literature review.Al-Mamari SA, Jourdan J, Boukaidi S, Quintens H, Marsaud A, Carpentier X, Arnaud P, Mentine N, Durand M, Amiel J, Chevallier D.Prog Urol. (2014)
• Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H. Eur Urol (2014)
• Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma.Chevalier N, Paul-Bellon R, Camparo P, Michiels JF, Chevallier D, Fénichel P.Int J Mol Sci. (2014)
• Connexin a check-point component of cell apoptosis in normal and physiopathological conditions.Carette D, Gilleron J, Chevallier D, Segretain D, Pointis G.Biochimie. (2014)
• Photovaporisation of the prostate using KTP laser in patients on antithrombotics. About a restrospective study of 120 cases.Mentine N, Boukaidi SA, Loeffler Mac-Neill J, Amiel J, Chevallier D.Prog Urol. (2013)
• Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes.Hijazi H, Chevallier D, Gal J, Chand ME, Gautier M, Hannoun-Levi JM.J Contemp Brachytherapy. (2013)
• The emerging role of connexin 43 in testis pathogenesis.Chevallier D, Carette D, Gilleron J, Segretain D, Pointis G.Curr Mol Med. (2013)
• Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.Chevallier D, Carette D, Segretain D, Gilleron J, Pointis G.Cell Mol Life Sci. (2013)
• Cosmetic surgery of the male genitalia.Chevallier D, Haertig A, Faix A, Droupy S.Prog Urol. (2013)
• Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes. Hijazi H, Chevallier D, Gal J, Chand ME, Gautier M, Hannoun-Levi JM. J Contemp Brachytherapy. (2013)
• Inflatable penile prosthesis: satisfaction rate, result, prognostic factors. Prospective study on 50 primooperated patients in CHU of Nice between 2000 and 2009.Obadia F, Mouracade P, Terrier JE, Amiel J, Gigante M, Li G, Chevallier D.Prog Urol. (2013)
• The emerging role of connexin 43 in testis pathogenesis.Chevallier D, Carette D, Gilleron J, Segretain D, Pointis G.Curr Mol Med. (2013)
• Connexin 43 a check-point component of cell proliferation implicated in a wide range of cell proliferationimplicated in a wide range of human testis diseases. Chevallier D, Carette D, Segretain D, Gilleron J, Pointis G.Cell Mol Life Sci. (2013)
• The place of simulation in the surgical resident curriculum. The pedagogic program of the Nice Medical School Simulation Center.Bréaud J, Chevallier D, Benizri E, Fournier JP, Carles M, Delotte J, Venissac N, Myx A, Ianelli A, Levraut J, Jones D, Benchimol D.J Visc Surg. (2012)
• Molecular connexin partner remodeling orchestrates connexin traffic: from physiology to pathophysiology.Gilleron J, Carette D, Chevallier D, Segretain D, Pointis G.Crit Rev Biochem Mol Biol. (2012)
• Evolution of prostate cancer brachytherapy.Hannoun-Levi JM, Chevallier D, Cosset JM, Gerbaulet A.Bull Cancer. (2012)
• Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L. BJU Int (2012)
• GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation.Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D, Fénichel P.PLoS One. (2012)
• Regenerating I messenger RNA and protein expression in the failing human testis: a potential molecular prognostic marker of seminoma.Mauro V, Volle DH, Chevallier D, Haudebourg J, Sénégas-Balas F, Pointis G.Hum Pathol. (2011)
• RET gene mutations are not involved in the origin of human testicular seminoma.Chevalier N, Barlier A, Roche C, Mograbi B, Camparo P, Devouassoux-Shisheboran M, Michiels JF, Nebout M, Chevallier D, Benahmed M, Enjalbert A, Fénichel P.Int J Androl. (2010)
• Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.Crouzet S, Rebillard X, Chevallier D, Rischmann P, Pasticier G, Garcia G, Rouviere O, Chapelon JY, Gelet A.Eur Urol. (2010)
• How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association.Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E.J Sex Med. (2008)
• Does management of erectile dysfunction after radical prostatectomy meet patients’ expectations? Results of a national survey (REPAIR) by the French Urological Association.Chartier-Kastler E, Amar E, Chevallier D, Montaigne O, Coulange C, Joubert JM, Giuliano F.J Sex Med. (2008)
• Reg I protein in healthy and seminoma human testis.Mauro V, Carette D, Chevallier D, Michiels JF, Segretain D, Pointis G, Sénégas-Balas F.Histol Histopathol. (2008)
• Unilateral testicular tumour associated to congenital adrenal hyperplasia: Failure of specific tumoral molecular markers to discriminate between adrenal rest and leydigioma.Fenichel P, Bstandig B, Roger C, Chevallier D, Michels JF, Sadoul JL, Hieronimus S, Brucker-Davis F.Ann Endocrinol. (2008)
• Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase.Roger C, Lambard S, Bouskine A, Mograbi B, Chevallier D, Nebout M, Pointis G, Carreau S, Fenichel P.J Mol Endocrinol. (2005)
• Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease.Roger C, Mograbi B, Chevallier D, Michiels JF, Tanaka H, Segretain D, Pointis G, Fenichel P.J Pathol. (2004)
• A weekly schedule of docetaxel for metastatic hormone-refractory prostate cancer.Ferrero JM, Foa C, Thezenas S, Ronchin P, Peyrade F, Valenza B, Lesbats G, Garnier G, Boublil JL, Tchiknavorian X, Chevallier D, Amiel J.Oncology. (2004)
• Efficacy of extracorporeal lithotripsy in acute renal colic: prospective study about 57 consecutive patients.Garcia G, Demey A, Chevallier D, Loeffler J, Gigante M, Toubol J, Amiel J.Prog Urol. (2004)
• Impaired gap junction connexin43 in Sertoli cells of patients with secretory azoospermia: a marker of undifferentiated Sertoli cells.Defamie N, Berthaut I, Mograbi B, Chevallier D, Dadoune JP, Fénichel P, Segretain D, Pointis G.Lab Invest. (2003)
• Update on cryptorchidism: endocrine, environmental and therapeutic aspects.Brucker-Davis F, Pointis G, Chevallier D, Fenichel P.J Endocrinol Invest. (2003)
• Development of narrow immobilized pH gradients covering one pH unit for human seminal plasma proteomic analysis.Starita-Geribaldi M, Roux F, Garin J, Chevallier D, Fénichel P, Pointis G.Proteomics. (2003)
• Mapping of seminal plasma proteins by two-dimensional gel electrophoresis in men with normal and impaired spermatogenesis.Starita-Geribaldi M, Poggioli S, Zucchini M, Garin J, Chevallier D, Fenichel P, Pointis G.Mol Hum Reprod. (2001)
• Nephrobronchial fistula secondary to xantogranulomatous pyelonephritis.Alifano M, Venissac N, Chevallier D, Mouroux J.Ann Thorac Surg. (1999)
• Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia.Fénichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G.Hum Reprod. (1999)
• A case of giant chondrosarcoma of the cricoid cartilage presenting as a superior mediastinal tumour.Guillem P, Porte H, Copin MC, Chevallier D.Eur J Cardiothorac Surg. (1998)
• A new vaginal procedure for cystocele repair and treatment of stress urinary incontinence. Benizri EJ, Volpé P, Pushkar D, Chevallier D, Amiel J, Sanian H, Toubol J.J Urol. (1996)
• Gangrene of the perineum. Benizri E, Fabiani P, Migliori G, Chevallier D, Peyrottes A, Raucoules M, Amiel J, Mouiel J, Toubol J. Urology. (1996)
• A novel technique for reconstruction of the abdominal wall in the prune belly syndrome.Monfort G, Guys JM, Bocciardi A, Coquet M, Chevallier D.J Urol. (1991)
• Transplantation and nephrectomy in autosomal dominant polycystic disease.Cassuto-Viguier E, Quintens H, Chevallier D, Derrier M, Jambou P, Toubol J, Duplay H.Clin Nephrol. (1991)
• Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports. Amiel J, Chevallier D, Peyrottes A, Benoliel J, Toubol J.Ann Urol. (1989)